BCLI
Barclays’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23,128
| Closed | -$6K | – | 4159 |
|
|
2023
Q4 | $6K | Buy |
+23,128
| New | +$6K | ﹤0.01% | 4067 |
|
|
2021
Q4 | – | Sell |
-4,267
| Closed | -$14K | – | 3273 |
|
|
2021
Q3 | $14K | Sell |
4,267
-3,721
| -47% | -$12.2K | ﹤0.01% | 3699 |
|
|
2021
Q2 | $31K | Sell |
7,988
-17,512
| -69% | -$68K | ﹤0.01% | 3587 |
|
|
2021
Q1 | $98K | Buy |
25,500
+16,810
| +193% | +$64.6K | ﹤0.01% | 3375 |
|
|
2020
Q4 | $39K | Sell |
8,690
-4,390
| -34% | -$19.7K | ﹤0.01% | 3257 |
|
|
2020
Q3 | $221K | Sell |
13,080
-1,587
| -11% | -$26.8K | ﹤0.01% | 2689 |
|
|
2020
Q2 | $164K | Buy |
+14,667
| New | +$164K | ﹤0.01% | 2903 |
|
|
2020
Q1 | – | Sell |
-3
| Closed | – | – | 3652 |
|
|
2019
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 3869 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 4191 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4202 |
|